Breaking News, Promotions & Moves

Takeda San Francisco

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Mary Haak-Frendscho, Ph.D. has been appointed president and chief scientific officer, Takeda San Francisco, Inc. Dr. Haak-Frendscho will be responsible for leading all activities at the company, including overall research and preclinical development, process development studies and operations for antibody therapeutics. Takeda San Francisco, established in November 2007, is a wholly owned subsidiary of Takeda Pharmaceutical Co. Ltd. of Osaka, Japan.           “Dr. Haak-Frendscho’s ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters